Found: 8
Select item for more details and to access through your institution.
Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1382, doi. 10.3390/cells9061382
- By:
- Publication type:
- Article
The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 19, p. 3119, doi. 10.3390/diagnostics13193119
- By:
- Publication type:
- Article
Peritoneal Tumor Carcinomatosis: Pharmacological Targeting with Hyaluronan-Based Bioconjugates Overcomes Therapeutic Indications of Current Drugs.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0112240
- By:
- Publication type:
- Article
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109427
- By:
- Publication type:
- Article
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation".
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.708073
- By:
- Publication type:
- Article
p53/ TP53 Status Assessment in Gastroesophageal Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2783, doi. 10.3390/cancers15102783
- By:
- Publication type:
- Article
Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092180
- By:
- Publication type:
- Article
The Feasibility and Diagnostic Adequacy of PD-L1 Expression Analysis Using the Cytoinclusion Technique in Bladder Cancer: A Prospective Single-Center Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 14, p. 4072, doi. 10.3390/jcm13144072
- By:
- Publication type:
- Article